23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › COGENT BIOSCIENCES INC. › 2023-2024

COGENT BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 6Reported items
  • 162Asset managers, any item
  • 1,348Fund votes
  • June 5, 2024Meeting date

Results at a glance

Meeting of June 5, 2024: 5 items on COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2024: 2 elected · 3 passed (calculated).

Dissent

Significant dissent: 1 director (32.2% against).

Notable dissent: 1 director (11.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COGENT BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by COGENT BIOSCIENCES INC.

These tallies are COGENT BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COGENT BIOSCIENCES INC. — official shareholder meeting results, meeting held June 5, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Andrew Robbins 67,815,951---- 8,532,4113,198,670 89%Elected—
Elect Director: Peter Harwin 51,730,466---- 24,617,8963,198,670 68%Elected—
2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 79,462,75379,1905,089 --0 99.9%Passed (calculated)—
3. Advisory Vote on Executive Compensation 69,604,5066,731,57512,281 --3,198,670 91%Passed (calculated)—
5. Approval of an Amendment to the Certificate of Incorporation 79,137,647393,22016,165 --0 99.5%Passed (calculated)—

Source: COGENT BIOSCIENCES INC., Form 8-K, filed with the SEC on June 5, 2024 — read the filing on EDGAR.

How asset managers voted at the COGENT BIOSCIENCES INC. 2023-2024 meeting

162 asset managers disclosed a vote on at least one COGENT BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of COGENT BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Andrew Robbins

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 67,815,951WITHHELD: 8,532,411
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Andrew Robbins

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Andrew Robbins”): 67,815,951 for, 8,532,411 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received a plurality of votes cast on Proposal 4 and each of the other proposals voted on were approved.”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 17,642,985 for, 7,985,341 withheld, 24,920 abstained.

FORWITHHOLD
FOR: 17,642,985ABSTAIN: 24,920WITHHOLD: 7,985,341
Largest asset managers voting on “Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and unt” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity1,311,5910 06,959,857Mixed
Vanguard5,618,9660 00For
State Street5,140,6040 05,808For
BlackRock1,942,8640 00For
TIAA1,028,0470 00For
Dimensional00 01,012,210Withhold
Charles Schwab623,6640 00For
Direxion Shares ETF Trust527,7230 00For
Delaware/Macquarie230,0000 00For
Equitable213,5740 00For
QUANTITATIVE MASTER SERIES LLC157,2730 00For
ProShares124,5400 00For
Exchange Place Advisors Trust98,4800 00For
Lincoln Financial70,4000 07,466Mixed
New York Life54,4990 00For
American Century52,0290 00For
Northern Trust43,6060 00For
AIG/SunAmerica40,9350 00For
Global X36,4870 00For
Pacific Life31,4300 00For
John Hancock31,1310 00For
JPMorgan28,0970 00For
Voya27,3200 00For
Jackson National00 24,9200Abstain
Bridge Builder Trust23,6550 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Elect Director: Peter Harwin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD
FOR: 51,730,466WITHHELD: 24,617,896
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Peter Harwin

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Peter Harwin”): 51,730,466 for, 24,617,896 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected, a frequency of one year received a plurality of votes cast on Proposal 4 and each of the other proposals voted on were approved.”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 10,981,647 for, 14,472,463 withheld, 199,136 abstained.

FORWITHHOLD
FOR: 10,981,647ABSTAIN: 199,136WITHHOLD: 14,472,463
Largest asset managers voting on “Election of the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders and unt” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity1,310,4410 06,961,007Mixed
Vanguard5,618,9660 00For
State Street55,9730 05,090,439Withhold
BlackRock1,942,8640 00For
TIAA1,028,0470 00For
Dimensional00 01,012,210Withhold
Charles Schwab623,6640 00For
Direxion Shares ETF Trust00 0527,723Withhold
Delaware/Macquarie00 0230,000Withhold
Equitable141,3740 072,200Mixed
QUANTITATIVE MASTER SERIES LLC157,2730 00For
ProShares00 0124,540Withhold
Exchange Place Advisors Trust00 98,4800Abstain
Lincoln Financial00 077,866Withhold
New York Life00 054,499Withhold
American Century00 052,029Withhold
Northern Trust00 043,606Withhold
AIG/SunAmerica00 040,935Withhold
Global X00 036,487Withhold
Pacific Life31,4300 00For
John Hancock00 31,1310Abstain
JPMorgan00 28,0970Abstain
Voya00 027,320Withhold
Jackson National00 24,9200Abstain
Bridge Builder Trust23,6550 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Approval of an Amendment to the Certificate of Incorporation

Calculated outcomeCAPITAL STRUCTUREPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 79,137,647AGAINST: 393,220
Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 150,000,000 to 300,000,000.

COGENT BIOSCIENCES INC.’s own tally for this item (“5. Approval of an Amendment to the Certificate of Incorporation”): 79,137,647 for, 393,220 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 25,653,246 for.

FOR
FOR: 25,653,246
Largest asset managers voting on “Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized sh” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity8,271,4480 00For
Vanguard5,618,9660 00For
State Street5,146,4120 00For
BlackRock1,942,8640 00For
TIAA1,028,0470 00For
Dimensional1,012,2100 00For
Charles Schwab623,6640 00For
Direxion Shares ETF Trust527,7230 00For
Delaware/Macquarie230,0000 00For
Equitable213,5740 00For
QUANTITATIVE MASTER SERIES LLC157,2730 00For
ProShares124,5400 00For
Exchange Place Advisors Trust98,4800 00For
Lincoln Financial77,8660 00For
New York Life54,4990 00For
American Century52,0290 00For
Northern Trust43,6060 00For
AIG/SunAmerica40,9350 00For
Global X36,4870 00For
Pacific Life31,4300 00For
John Hancock31,1310 00For
JPMorgan28,0970 00For
Voya27,3200 00For
Jackson National24,9200 00For
Bridge Builder Trust23,6550 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Advisory Vote on Executive Compensation

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 8 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 69,604,506AGAINST: 6,731,575
Details: description as filed, official tally, votes by 161 asset managers

Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.

COGENT BIOSCIENCES INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 69,604,506 for, 6,731,575 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 50 asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity8,271,4480 00For
Vanguard5,618,9660 00For
State Street5,134,02512,387 00For
BlackRock1,942,8640 00For
TIAA1,028,0470 00For
Dimensional01,012,210 00Against
Charles Schwab0623,664 00Against
Direxion Shares ETF Trust527,7230 00For
Delaware/Macquarie230,0000 00For
Equitable213,5740 00For
QUANTITATIVE MASTER SERIES LLC157,2730 00For
ProShares124,5400 00For
Exchange Place Advisors Trust098,480 00Against
Lincoln Financial70,4007,466 00Mixed
New York Life54,4990 00For
American Century052,029 00Against
Northern Trust43,6060 00For
AIG/SunAmerica40,9350 00For
Global X036,487 00Against
Pacific Life31,4300 00For
John Hancock31,1310 00For
JPMorgan28,0970 00For
Voya27,3200 00For
Jackson National024,920 00Against
Bridge Builder Trust23,6550 00For

Fund voting reports, all 50 managers: 23,740,385 for, 1,912,861 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 126 asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity6,966,2930 00For
TCG Crossover Management, LLC6,964,3750 00For
Kynam Capital Management, LP00 06,643,660Withhold
State Street6,515,67512,439 00For
COMMODORE CAPITAL LP6,425,0000 00For
Point726,093,5560 00For
Fairmount Funds Management LLC4,725,6410 00For
VR Adviser, LLC4,684,1670 00For
Redmile Group, LLC02,612,602 00Against
Vivo Capital, LLC2,244,9410 00For
BlackRock2,039,82410,891 00For
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,534,3450 00For
GEODE CAPITAL MANAGEMENT, LLC1,389,4390 00For
Sofinnova Investments, Inc.1,228,5950 00For
Nuveen1,032,0910 00For
Saturn V Capital Management LP746,9060 00For
5AM Venture Management, LLC710,4910 00For
SILVERARC CAPITAL MANAGEMENT, LLC689,7870 00For
Charles Schwab0623,664 00Against
Nantahala Capital Management, LLC587,9550 00For
PERCEPTIVE ADVISORS LLC583,3330 00For
Rafferty Asset Management, LLC527,7230 00For
KENNEDY CAPITAL MANAGEMENT LLC474,74829,231 00Mixed
Northern Trust454,987657 00For
Avidity Partners Management LP445,3610 00For

Institutional-manager reports, all 126 managers: 61,009,730 for, 4,135,492 against, 6,643,660 withheld, 46,063 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 157 asset managers

Description as filed by funds: Advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 50 asset managers voting on “Advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named e” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity00 00--
Vanguard00 00--
State Street00 00--
BlackRock00 00--
TIAA00 00--
Dimensional00 00--
Charles Schwab00 00--
Direxion Shares ETF Trust00 00--
Delaware/Macquarie00 00--
Equitable00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
ProShares00 00--
Exchange Place Advisors Trust00 00--
Lincoln Financial00 00--
New York Life00 00--
American Century00 00--
Northern Trust00 00--
AIG/SunAmerica00 00--
Global X00 00--
Pacific Life00 00--
John Hancock00 00--
JPMorgan00 00--
Voya00 00--
Jackson National00 00--
Bridge Builder Trust00 00--

Fund voting reports, all 50 managers: 5,861 for, 24,602,789 1 year, 1,044,596 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 122 asset managers voting on “Advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named e” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity00 00--
TCG Crossover Management, LLC00 00--
State Street00 00--
COMMODORE CAPITAL LP00 00--
Point7200 00--
Fairmount Funds Management LLC00 00--
VR Adviser, LLC00 00--
Redmile Group, LLC00 00--
Vivo Capital, LLC00 00--
BlackRock00 00--
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Sofinnova Investments, Inc.00 00--
Nuveen00 00--
Saturn V Capital Management LP746,9060 00For
5AM Venture Management, LLC00 00--
SILVERARC CAPITAL MANAGEMENT, LLC00 00--
Charles Schwab00 00--
Nantahala Capital Management, LLC00 00--
PERCEPTIVE ADVISORS LLC00 00--
Rafferty Asset Management, LLC00 00--
KENNEDY CAPITAL MANAGEMENT LLC00 00--
Northern Trust00 00--
Avidity Partners Management LP00 00--
Janus Henderson00 00--

Institutional-manager reports, all 122 managers: 1,043,770 for, 50 against, 63,688,086 1 year, 104,673 3 year, 9 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 79,462,753AGAINST: 79,190

Prior year: 100.0% for (June 7, 2023 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 50 asset managers

Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.

COGENT BIOSCIENCES INC.’s own tally for this item (“2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm”): 79,462,753 for, 79,190 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 50 asset managers below reported 25,644,150 for, 9,096 against.

FOR
FOR: 25,644,150AGAINST: 9,096
Largest asset managers voting on “Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public acc” at COGENT BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity8,271,4480 00For
Vanguard5,618,9660 00For
State Street5,137,5208,892 00For
BlackRock1,942,8640 00For
TIAA1,028,0470 00For
Dimensional1,012,2100 00For
Charles Schwab623,6640 00For
Direxion Shares ETF Trust527,7230 00For
Delaware/Macquarie230,0000 00For
Equitable213,5740 00For
QUANTITATIVE MASTER SERIES LLC157,2730 00For
ProShares124,5400 00For
Exchange Place Advisors Trust98,4800 00For
Lincoln Financial77,8660 00For
New York Life54,4990 00For
American Century52,0290 00For
Northern Trust43,6060 00For
AIG/SunAmerica40,9350 00For
Global X36,4870 00For
Pacific Life31,4300 00For
John Hancock31,1310 00For
JPMorgan28,0970 00For
Voya27,3200 00For
Jackson National24,9200 00For
Bridge Builder Trust23,6550 00For

Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).

Largest COGENT BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 95,613,396 shares outstanding at the time of that meeting.

Fund voting reports: top COGENT BIOSCIENCES INC. shareholders by shares voted on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 8.65%
2Vanguard 5.88%
3State Street 5.38%
4BlackRock 2.03%
5TIAA 1.08%
6Dimensional 1.06%
7Charles Schwab 0.65%
8Direxion Shares ETF Trust 0.55%
9Delaware/Macquarie 0.24%
10Equitable 0.22%
Institutional-manager reports: top COGENT BIOSCIENCES INC. shareholders by shares voted on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 7.29%
2TCG Crossover Management, LLC 7.28%
3Kynam Capital Management, LP 6.95%
4State Street 6.83%
5COMMODORE CAPITAL LP 6.72%
6Point72 6.37%
7Fairmount Funds Management LLC 4.94%
8VR Adviser, LLC 4.90%
9Redmile Group, LLC 2.73%
10Vivo Capital, LLC 2.35%

Reported COGENT BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

COGENT BIOSCIENCES INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)22,408,263 —Form 13F, quarter ended March 31, 2024
Venrock Healthcare Capital Partners II, L.P.11,516,667 —Schedule 13G, filed November 14, 2024
Entities affiliated with FMR LLC10,636,187 —Proxy statement (DEF 14A), proxy filed April 23, 2024
BlackRock10,369,535 —Form 13F, quarter ended March 31, 2024
Entities affiliated with Fairmount Funds Management LLC9,986,556 —Proxy statement (DEF 14A), proxy filed April 23, 2024
Entities affiliated with Kynam Capital Management, LP8,508,139 —Proxy statement (DEF 14A), proxy filed April 23, 2024
Vanguard Group7,757,662 —Form 13F, quarter ended March 31, 2024
State Street7,626,869 —Form 13F, quarter ended March 31, 2024
Entities affiliated with Venrock Healthcare Capital Partners II, L.P.6,891,917 —Proxy statement (DEF 14A), proxy filed April 23, 2024
Entities affiliated with BlackRock, Inc.6,755,584 —Proxy statement (DEF 14A), proxy filed April 23, 2024

Percentages above are of 95,613,396 shares outstanding, as reported by COGENT BIOSCIENCES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At COGENT BIOSCIENCES INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 162 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,348 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: COGENT BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COGENT BIOSCIENCES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

COGENT BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “COGENT BIOSCIENCES (COGT) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/cogent-biosciences-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.